Insider Selling: Quantum-Si incorporated (NASDAQ:QSI) CEO Sells $32,952.73 in Stock

Quantum-Si incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins sold 23,707 shares of the stock in a transaction on Friday, March 21st. The shares were sold at an average price of $1.39, for a total transaction of $32,952.73. Following the sale, the chief executive officer now directly owns 2,646,716 shares of the company’s stock, valued at $3,678,935.24. The trade was a 0.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Quantum-Si Trading Down 1.4 %

Shares of QSI opened at $1.39 on Thursday. Quantum-Si incorporated has a 1-year low of $0.61 and a 1-year high of $5.77. The firm’s 50-day moving average price is $1.75 and its 200-day moving average price is $1.49. The firm has a market capitalization of $254.56 million, a price-to-earnings ratio of -2.17 and a beta of 2.75.

Institutional Trading of Quantum-Si

Several large investors have recently bought and sold shares of the company. Barclays PLC boosted its holdings in shares of Quantum-Si by 210.5% during the 3rd quarter. Barclays PLC now owns 196,826 shares of the company’s stock valued at $173,000 after buying an additional 133,438 shares in the last quarter. SBI Securities Co. Ltd. bought a new stake in Quantum-Si during the fourth quarter worth about $60,000. Sanctuary Advisors LLC purchased a new stake in Quantum-Si in the fourth quarter worth about $95,000. Geode Capital Management LLC increased its stake in shares of Quantum-Si by 6.7% during the third quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company’s stock valued at $2,044,000 after purchasing an additional 145,091 shares in the last quarter. Finally, Dudley Capital Management LLC purchased a new position in shares of Quantum-Si during the fourth quarter valued at approximately $30,000. 39.90% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

QSI has been the subject of several recent analyst reports. National Bankshares set a $3.65 price objective on shares of Quantum-Si in a research note on Wednesday, March 5th. HC Wainwright reaffirmed a “buy” rating and set a $5.50 price target on shares of Quantum-Si in a research report on Tuesday, January 14th. Finally, Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a research report on Wednesday, March 5th.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.